This proposal seeks to identify cancer specific gene mutations that are linked with important clinical and epidemiological characteristics of colon cancer (CC). 'Driver'gene mutations are directly related to clinical behavior in virtually all cancers. However, mutations that drive CC progression, from the eady curable disease to late stage incurable disease, are yet to be identified. Recent studies by our group and our collaborators have identified 140 candidate cancer genes (CAN genes) in CC. We also found that virtually all the CAN gene mutations found in metastatic CCs are also found in the antecedent primary cancer. This surprising result gives us an opportunity to explore CAN gene mutations in multiple clinical settings. To enable these studies, we have constructed a large biorepository containing CCs from patients treated at a large medical center over the last 20 years. The majority of these specimens are formalin-fixed paraffin embedded [FFPE]. We have developed sophisticated approaches to enhance the utility of DNA extracted from FFPE materials. These include reliable extraction of large DNA fragments. We also developed the technologies and processes to 'DNA capture'targeted exonal fragments and identify mutations from FFPE material using a 'next generation'sequencer. We have developed an infrastructure and knowledge base to support high throughput tissue processing and sequencing. We propose to use these methods to identify CAN gene mutations which appear only in late stage CCs. Also we will functionally dissect the role of these genes using cell line and xenograft mouse models. As CC is one of the cancers with significant disparities attributed to race and gender associated etiologic factors, we will compare CC CAN gene mutations between African American and white patients and between females and male patients, of similar cancer stage and outcome. The former studies will be facilitated by our use of an Ancestry Informative Marker- SNP classification of patients which will be incorporated directly into the DNA sequencing analyses. Our proposals have the potential to significantly advance the understanding of the biological basis for cancer metastasis and to gain insights into racial/gender based differences in etiology and outcomes among CC patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA150964-04
Application #
8711345
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
4
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Type
DUNS #
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Kendall, Bradley J; Rubenstein, Joel H; Cook, Michael B et al. (2016) Inverse Association Between Gluteofemoral Obesity and Risk of Barrett's Esophagus in a Pooled Analysis. Clin Gastroenterol Hepatol 14:1412-1419.e3
Thota, Prashanthi N; Zackria, Shamiq; Sanaka, Madhusudhan R et al. (2016) Racial Disparity in the Sex Distribution, the Prevalence, and the Incidence of Dysplasia in Barrett's Esophagus. J Clin Gastroenterol :
Parameswaran, Reshmi; Ramakrishnan, Parameswaran; Moreton, Stephen A et al. (2016) Repression of GSK3 restores NK cell cytotoxicity in AML patients. Nat Commun 7:11154
Peyser, Noah D; Wang, Lin; Zeng, Yan et al. (2016) STAT3 as a Chemoprevention Target in Carcinogen-Induced Head and Neck Squamous Cell Carcinoma. Cancer Prev Res (Phila) 9:657-63
Cui, Min; Awadallah, Amad; Liu, Wendy et al. (2016) Loss of Hes1 Differentiates Sessile Serrated Adenoma/Polyp From Hyperplastic Polyp. Am J Surg Pathol 40:113-9
Venkitachalam, Srividya; Revoredo, Leslie; Varadan, Vinay et al. (2016) Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer. Sci Rep 6:23642
Fecteau, Ryan E; Kong, Jianping; Kresak, Adam et al. (2016) Association Between Germline Mutation in VSIG10L and Familial Barrett Neoplasia. JAMA Oncol 2:1333-1339
Sun, Xiangqing; Elston, Robert C; Barnholtz-Sloan, Jill S et al. (2016) Predicting Barrett's Esophagus in Families: An Esophagus Translational Research Network (BETRNet) Model Fitting Clinical Data to a Familial Paradigm. Cancer Epidemiol Biomarkers Prev 25:727-35
Russo, Suzanne; Ammori, John; Eads, Jennifer et al. (2016) The role of neoadjuvant therapy in pancreatic cancer: a review. Future Oncol 12:669-85
Eads, Jennifer R; Beumer, Jan H; Negrea, Lavinia et al. (2016) A pharmacokinetic analysis of cisplatin and 5-fluorouracil in a patient with esophageal cancer on peritoneal dialysis. Cancer Chemother Pharmacol 77:333-8

Showing the most recent 10 out of 118 publications